The PHUSE Board of Directors has a rotation policy of its members so that it does not become static and introduces new blood and ideas into the group. A standard rotation is three years. This year the following positions were advertised: Operations, EMEA, Membership, Special Projects and the new role of Collaborations Director.
Having spoken to a great many people, we had several applications for the roles. After a long discussion, the following roles were appointed…
Three Directors chose to re-stand for their positions – Adrienne Bonwick for Operations, John Salter for EMEA, and Yvonne Moores as Special Projects – and all were accepted.
After many years as Membership Director, Frank Senk decided not to stand and Sangeeta Bhattacharya (profile below) was voted onto the Board. The Board would like to note its thanks for the exceptional work Frank has done in increasing the membership, in particular with the group membership.
The new role of Collaborations Director was created after the resignation of Scott Bahlavooni from the joint Working Groups Director role. Scott was key in the creation of this position and the interactions with the FDA, and the Board would like to thank him for his contribution. Lisa Brooks has joined the Board to take on this newly created position (profile below).
Both Lisa and Sangeeta join the Board with immediate effect. We would like to thank all applicants for their consideration and hope to include several to other wider roles within PHUSE.
Further details on the structure of the Board can be found here.
Written by Adrienne Bonwick, Operations Director
Sangeeta Bhattacharya is the Statistical Programming and Analysis Head for Immunology at Janssen Research & Development. For the last 21 years, Sangeeta has led, mentored and organised large high-performing global teams of statistical programmers/analysts in companies including Novartis, Merck, Abbott and BMS. She fosters trust through mentoring and collaboration and inspires by example. As an active PHUSE member, Sangeeta is on the planning committee for various conferences. She has presented widely and, in 2015, was keynote speaker for PharmaSUG, China. She has a master’s in biostatistics with a minor in epidemiology from the School of Public Health, University of Texas.
Lisa Brooks first attended the CSS in 2012 and became active in a PHUSE Working Group from 2015 until becoming a Co-Chair in 2017 of the Optimizing the Use of Data Standards Working Group, bringing broad and diverse real work experience to the development of the Study Data Standardization Plan, the Legacy Data Conversion Plan and Report, and many other projects via the Steering Committee. In her day job, Lisa is a business owner and provider of technical advice, leadership, and project management to biotech and pharmaceutical companies in their data submissions for BLAs and NDAs.
